Latest / In Good Company with Nicolai Tangen
GSK CEO: Drug Discovery, AI in Pharma, and Changing Company Culture
How is the pharmaceutical industry evolving to meet the world’s biggest health challenges? In this episode, Nicolai Tangen sits down with Emma Walmsley, CEO of GSK, for an insightful conversation about the future of pharmaceuticals. They discuss GSK’s latest advances in cancer treatments, HIV therapies, and respiratory medicine, as well as the role of AI in speeding up drug discovery. Emma also shares her thoughts on navigating change, transforming company culture, and the role of curiosity in staying motivated. Tune in!
In Good Company is hosted by Nicolai Tangen, CEO of Norges Bank…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.